Carlos Alvarez

Cardiología en HC CMN SXXI @UNAM_MX 🫀🩺. | 🌵☀️ | 🏈 ⚾️
Fellow Cardiología Intervencionista

[Carlos Alvarez @CarlosAlvarezDM]

Le llaman suerte pero es preparación y constancia...

[Cristina Tejera @cristinatejerap]

¿Cuándo elegir semaglutida y cuándo tirzepatida?
La EASO acaba de actualizar su algoritmo con evidencia hasta noviembre 2025 📊 @EASOobesity

Spoiler: depende del objetivo clínico. No es solo pérdida de peso.

🔗 @NatureMedicine

https://t.co/RKkccNGYTq

#ECO2026

[Juan Pablo Costabel MD 🇦🇷 @jpcostabel]

“Tenía el colesterol normal y aun así tuvo un infarto.”
👉 En realidad, el 99% de los casos de infarto, ACV o insuficiencia cardíaca presentan algún nivel no óptimo de presión, colesterol, glucosa o tabaquismo.
No hay riesgo cero. Solo prevención temprana. 🫀 #CardioTwitter
https://t.co/4xXsE6pIym

[Ahmed Mohsen @drahmedmohsen85]

🎯 2025 ESC Guideline Update

Low-Flow, Low-Gradient AS + ↓EF

🫀 Old: Mandatory Dobutamine Stress Echo (DSE)
🆕 New: DSE not mandatory ��� → Use CT Aortic Valve Calcium Score (AVCS) ✅

📌 Severe AS:
👩 >1200 AU
👨 >2000 AU

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Acute coronary syndromes: mechanisms, challenges, and new opportunities: @ESC_Journals

🥸Very nice review -

😱Many research questions

👇👇👇

[Ahmed Ata @Ahmedata7777]

Intervention Strategies For Dyslipidaemia

ESC Guidelines

📌 Key Insight
● Even if a patient has low CV risk, very high LDL-C (≥190 mg/dL) warrants drug treatment.

● In contrast, very high-risk patients need drug therapy even at relatively low LDL-C levels (like ≥1.4 mmol/L).

● Numbers: 55, 70, 100, 116, 190
● CV Risk: low, moderate, high, very high risk.

[Ritika Tuli @RitikaTuliMD]

#CardioNuggets:

DeWinter T-Waves = STEMI Equivalent!
Don’t be fooled by the absence of ST elevation

J-point upsloping ST depression (1–3 mm) in V1–V6
Tall, symmetric T waves in precordial leads
+/- ST��� in aVR

Strongly suggests proximal LAD occlusion

#FOAMed #CardioTwitter #ECG #STEMIequivalent #DeWinter

[Julia Seller @JuliaSellerm]

Top3 heart failure trials in April 2025

🥇Dapagliflozin in patients undergoing TAVI @NEJM

🥈Liberal fluid intake vs fluid restriction in chronic HF @NatureMedicine

🥉Management of HF with improved EF @JACCJournals

[CardiovascularCorner @TrackYourHeart]

Coronary Artery Dominance: A Key Concept in Angiography

Dominance is defined by which artery gives rise to the posterior descending artery (PDA):
• Right dominance – PDA from RCA
• Left dominance – PDA from LCx
• Balanced – PDA from both RCA & LCx

Prevalence:
• Right dominant – ~85%
• Left dominant – ~8%
• Balanced – ~7%

Understanding dominance is crucial in assessing myocardial perfusion, planning revascularization, and anticipating outcomes in coronary artery disease.

Image:
Top – Right dominance
Middle – Left dominance
Bottom – Balanced dominance
(Courtesy Dr. Annapoorna Kini, Mount Sinai, NY)

Ref: Braunwald’s Heart Disease, 12th Ed.

#Cardiology #MedicalEducation #InterventionalCardiology

[Juan José Amaro A @jjamaro]

#ACC25
Resumen de conclusiones de los 23 estudios presentados en las 6 sesiones LBCT del ACC25
Chicago, IL – EU, 29-31 marzo 2025
��Rumbo al MECA-ACC25 de la Sociedad Venezolana de Cardiología
@CardiologiaSVC 
@torresviera
@mencardio

[Alfredo Harp Helú @alfredoharphelu]

Qué felicidad se siente cuando veo debutar a @omarcruz01 en @MLB @Padres, egresado de la @AcademiaAHH que apuesta por el talento mexicano. Enhorabuena!

[Dr Roxana Mehran @Drroxmehran]

#ACC2025 LBCT
💉 Bentracimab shows promise in REVERSE-IT Phase 3! @DLBHATTMD
✅ Rapid reversal of ticagrelor’s antiplatelet effect
✅ Effective hemostasis in 94% of cases
✅ No serious safety concerns
✅ Ideal for urgent surgery/bleeding cases
🔹 granted orphan drug status by FDA

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Dapagliflozin in Patients Undergoing Transcatheter Aortic-Valve Implantation: @NEJM

🥸 Trials at #ACC25 - Dapagliglozin in pts with TAVR!

😱 Summary

👇👇👇👇

[Gonzalo Perez @gonzaeperez]

#ACC25 RIVAWAR trial
🔴Rivaroxa 🆚 warfarina en trombo ventricular izquierdo post IAM
🔴Riva tuvo eficacia similar a warfa en resolución del trombo VI a 3 meses
🔴No hubo ⬆️sangrado
@ACCinTouch #STEMI #NSTEMI

[Abdulla A. Damluji, MD, PhD @DrDamluji]

Rotational Atherectomy, Lithotripsy, or Laser for Calcified Coronary Stenosis: The ROLLER COASTR-EPIC22 Trial: @JACCJournals

🥸 Good morning

😱 Let's summarize

👇👇👇

[Carlos Alvarez @CarlosAlvarezDM]

@ValdoCasMtz @mauriciopedroza Mal día para KC. 🫠

[Gonzalo Perez @gonzaeperez]

GUÍAS ESC 2024 DE HIPERTENSIÓN ARTERIAL
Buen resumen 👌
Vía @ESC_Journals
https://t.co/zQEcGSIzFj

[Gonzalo Perez @gonzaeperez]

MANEJO DEL PACIENTE POST - #PCI
Revisión @JACCJournals

✍️3 pilares
🔴Modificaciones en estilo de vida 🏃‍♀️🏋️‍♂️🥦
🔴Medicación para prevención secundaria💊
🔴Monitoreo de la reestenosis

https://t.co/wXaZNpYxw4

[EHJ Editor-in-Chief @ehj_ed]

The 2024 top 10 papers in heart failure!!!
https://t.co/ZRjH2zplDY
#cardiotwitter, @ESC_Journals, @escardio

[Enrique Santas @SantasEnrique]

NT-proBNP para el diagnóstico ambulatorio de IC-FEp @CircAHA

🚨 Inconsistencia del punto de corte actual de 125 pg/ml
👉 Diferente punto de corte en función del IMC
IMC <35 —> rule out 50 pg/ml
rule in 500 pg/ml
IMC>35 —> rule out 35 pg/ml
rule in 220 pg/ml
👉 Poca utilidad si FA (sospecha IC + FA= IC) @secardiologia @SVCardio

[Mednomics @mednomics]

Cardiologist vs Nephrologist when IV diuretic is administered